Aloka Medical Device Company Intelligence Report

Date: November 22, 2010
Pages: 18
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A9EEA662DD5EN
Leaflet:

Download PDF Leaflet

Aloka Medical Device Company Intelligence Report
The history of Aloka began in 1950 when the medical equipment department of Japan Radio Company became an independent company, Medical and Physical Institute Co Ltd. In 1976, the company’s name was changed to Aloka, which means “ray of hope” in ancient Sanskrit.

Aloka’s operations are divided within three product segments: Electronic Medical Systems (including diagnostic ultrasound systems, bone densitometry systems and medical treatment and surgery systems), General Analysis Systems (including radiation measuring instruments, radio control instruments, analysis systems using radiation and bio-related systems) and Medical Analysis Systems (laboratory test systems, pipettors, and emission and spectroscopic analysis systems). This profile focuses on the Electronic Medical Systems activities.

As a manufacturer of medical ultrasound equipment, Aloka’s most significant achievements include the development of the world’s first diagnostic ultrasound system – the SSD-2 – in 1960 and the first Colour Doppler system in 1983. Aloka's worldwide headquarters is located in Tokyo, Japan. It operates 40 domestic and 16 overseas business establishments, including subsidiaries. The company’s US headquarters is located in Wallingford, Connecticut, and its European headquarters is in Zug, Switzerland. Aloka exports its products to more than 150 countries.

In 1992, Aloka formed a joint venture in Shanghai, China. The joint venture, Shanghai Aloka Medical Equipment Co Ltd, was the first Sino-Japanese joint venture producing medical ultrasonic diagnostic apparatus in China. A joint venture with Trivitron Medical Systems in India was established in April 2009 and is producing ultrasound systems for the Asian markets. Aloka’s competitors include Dräger Medical, GE Healthcare, Siemens, Toshiba and Philips.

In the year ended 31st March 2010, Aloka generated net earnings of ¥662 million on consolidated net sales of ¥45,811 million.

Hitachi Medical is the second-largest shareholder in Aloka, with a 12.34% interest as of 31st March 2010.

This company report provides

Executive Summary

An overview of the company, including operating activities and latest results, at a glance key events and strategic focus.

Product Portfolio and R&D

The product section of the report focuses on the key aspects of the company's portfolio and technology, covering core products, key brands, new products and analysis of the competition. Sales data, market size and future potential is included where available.

The R&D section answers questions such as:
  • Where is the research based?
  • How much has been invested in R&D?
  • What is in the product pipeline?
  • What competing products are in development or already on the market?
  • What R&D agreements does the company have?

International Activities

The company's revenues, assets and business activities by geographic region and country.
  • Appendices
  • Agreements
  • Mergers & Acquisitions
  • Key Corporate Events
OVERVIEW

FINANCIAL REVIEW

Fiscal Year 2010 Financial Results
Five-Year Financial Data
Outlook

STRATEGIC FOCUS

PRODUCTS

Medical Electronic Systems
Diagnostic Ultrasound Systems
Transducers
Bone Densitometry Systems
AOS-100NW
DCS-600EX-III
Medical Analysis Systems
General Analysis Systems

RESEARCH AND DEVELOPMENT

New Technology

MANUFACTURING AND DISTRIBUTION

Manufacturing
Distribution

AGREEMENTS

RFA Medical
LI-COR Biosciences
Olympus Medical Systems
Xilinx
Hitachi Medical
Terason
SonoSite
Cedara Software
Hologic
Civco Medical Solutions

MERGERS AND ACQUISITIONS

Biomedic Belgium
Ecotron Holding

KEY CORPORATE EVENTS

LIST OF TABLES

SUMMARY OPERATING RESULTS

Recent Key Events
Aloka – Annual Financial Results, 2006-2010
Aloka – Annual Sales by Business Area, 2006-2010
Aloka – Annual Group Sales by Geographic Area, 2006-2010
Aloka – Five-Year Financial Summary
Aloka – Consolidated Net Sales and Operating Income Targets to 31st March 2013
Aloka – Annual R&D Expenditure, 2006-2010
Agreements Summary

LIST OF CHARTS

Aloka - Annual Net Sales and Operating Income, 2006-2010
Aloka - Annual Sales by Business Area, 2006-2010
Aloka - Annual Sales by Geographic Area, 2006-2010
Aloka - Fiscal 2010 Sales by Business Area
Skip to top


St Jude Medical Device Company Intelligence Report US$ 515.00 Jul, 2013 · 46 pages
Zimmer Medical Device Company Intelligence Report US$ 515.00 Jun, 2012 · 48 pages
Bard Medical Device Company Intelligence Report US$ 515.00 Aug, 2011 · 48 pages
Cordis Medical Device Company Intelligence Report US$ 340.00 Jul, 2013 · 34 pages

Ask Your Question

Aloka Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: